- Filed
- Jun 17, 2026 11:48 AM ET
- Period of report
- Jun 17, 2026
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Jun 17, 2026 | 207.03M sh |
| Cash And Equivalents | 2025 · Oct 31, 2025 | $1.96K |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $0 |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $0 |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 207.03M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 207.03M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 207.03M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 207.03M sh |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | −$2.81K |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | −$12.89K |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | −$4.35M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | −$4.21M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | −$4.1M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | −$4.02M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | −$3.87M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | −$3.7M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | −$3.53M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | −$3.35M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $4.37M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $4.03M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $4.37M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $4.03M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $9.83K |
| Current Assets | Q3 2026 · Jan 31, 2025 | $272 |
| Total Assets | Q3 2026 · Oct 31, 2025 | $16.47K |
| Total Assets | Q3 2026 · Jan 31, 2025 | $14.38K |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.00 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.00 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $135.73K |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $303.95K |
| Sga Expense restated | Q3 2026 · Oct 31, 2024 | $117.93K |
| Sga Expense restated | Q3 2026 · Oct 31, 2024 | $553.42K |
| Net Income | Q3 2026 · Oct 31, 2025 | −$142.52K |
| Net Income | Q3 2026 · Oct 31, 2025 | −$333.9K |
| Net Income | Q3 2026 · Jul 31, 2025 | −$110.85K |
| Net Income | Q3 2026 · Apr 30, 2025 | −$80.54K |
| Net Income | Q3 2026 · Oct 31, 2024 | −$196.29K |
| Net Income | Q3 2026 · Oct 31, 2024 | −$631.79K |
| Net Income | Q3 2026 · Jul 31, 2024 | −$218.66K |
| Net Income | Q3 2026 · Apr 30, 2024 | −$216.83K |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$135.73K |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$303.95K |
| Operating Income restated | Q3 2026 · Oct 31, 2024 | −$117.93K |
| Operating Income restated | Q3 2026 · Oct 31, 2024 | −$553.42K |
| Revenue | Q3 2026 · Oct 31, 2025 | $0 |
| Revenue | Q3 2026 · Oct 31, 2025 | $0 |
| Revenue | Q3 2026 · Oct 31, 2024 | $0 |
| Revenue | Q3 2026 · Oct 31, 2024 | $0 |